Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuphoria Therapeutics (NEUP) Exchange Rate Effect (2024 - 2025)

Neuphoria Therapeutics (NEUP) has disclosed Exchange Rate Effect for 2 consecutive years, with $295406.0 as the latest value for Q4 2025.

  • On a quarterly basis, Exchange Rate Effect rose 206.76% to $295406.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $410526.0, a N/A change, with the full-year FY2025 number at -$3750.0, down 104.87% from a year prior.
  • Exchange Rate Effect was $295406.0 for Q4 2025 at Neuphoria Therapeutics, up from -$19455.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $295406.0 in Q4 2025 to a low of -$276692.0 in Q4 2024.